RETRACTED: Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions

Sudbø, Jon; Ristimäki, Ari; Sondresen, Jan Erik; Kildal, Wanja; Boysen, Morten; Koppang, Hanna S.; Reith, Albrecht; Risberg, Björn; Nesland, Jahn M.; Bryne, Magne

doi:10.1016/S1368-8375(03)00012-5

« Previous Next »Oral Oncology
Volume 39, Issue 5 , Pages 497-505, July 2003

RETRACTED: Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions☆

Jon Sudbø
- Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo 0310, Norway
- Corresponding author
Ari Ristimäki
- Department of Pathology, Helsinki University Central Hospital and Molecular and Cancer Biology Research Program, University of Helsinki, Finland
Jan Erik Sondresen
- Department of Oral Biology, Oslo, Norway
Wanja Kildal
- Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Morten Boysen
- Department of Oto-Rhino-Laryngology, The National Hospital, Oslo, Norway
Hanna S. Koppang
- Department of Clinical Dentistry, University of Oslo, Oslo, Norway
- Department of Pathology and Forensic Odontology, University of Oslo, Oslo, Norway
Albrecht Reith
- Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Björn Risberg
- Department of Pathology, Helsinki University Central Hospital and Molecular and Cancer Biology Research Program, University of Helsinki, Finland
Jahn M. Nesland
- Department of Pathology, Helsinki University Central Hospital and Molecular and Cancer Biology Research Program, University of Helsinki, Finland
Magne Bryne
- Department of Oral Biology, Oslo, Norway

This article has been retracted at the request of Oral Oncology and the co-authors. Please see http://www.elsevier.com/locate/withdrawalpolicy.

Reason: The lead author, Jon Sudbø, has been found by the Investigating Commission (appointed in January 2006 by Rikshospitalet - Radiumhospitalet MC and the University of Oslo to investigate Dr Sudbø's misconduct) to have fabricated and modified the data on which the analyses were based.

The above mentioned Investigating Commission has determined that Dr Sudbø acted alone in fabricating the data.

Dr Sudbø disputes the findings of the Investigating Commission.

Reference: Ekbom A, Helgesen GEM, Lunde T, Tverdal A, Vollset SE, Simonsen S. Report from the Investigating Commission appointed by Rikshospitalet - Radiumhospitalet MC and the University of Oslo, January 18, 2006.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

☆ None of the listed authors or acknowledged persons have any conflicts of interest, financially or personally, in relation to the data presented in the article. Presented in part at The Premier International Meeting on Cancer Prevention Research—Frontiers in Cancer Prevention Research, 14–18 October, 2002, Boston, and at the 14th EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer Therapeutics”, 19–22 November, 2002, Frankfurt, Germany.

PII: S1368-8375(03)00012-5

doi:10.1016/S1368-8375(03)00012-5

Refers to erratum:

Retraction notice to ‘Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions’ [Oral Oncol. 39 (2003) 497–505]
J. Sudbø, A. Ristimaki, J.E. Sondresen, W. Kildal, M. Boysen, H.S. Koppang, A. Reith, B. Risberg, J.M. Nesland, M. Bryne
Oral Oncology April 2007 (Vol. 43, Issue 4, Page 420)
- Full Text
- PDF (71 KB)